Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 1/20 | 0.34 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6621823 | 0.75 | ALDH1A1 (0.40) | LGALS8LGALS3ALDH1A1HPGDTSHR | |
| SCHEMBL7252974 | 0.72 | CA12 (0.43) | LGALS8LGALS3ALDH1A1HPGDTSHR | |
| SCHEMBL3569943 | 0.71 | ALDH1A1 (0.37) | LGALS8LGALS3ALDH1A1HPGDTSHR | |
| SCHEMBL1177539 | 0.69 | ALDH1A1 (0.44) | LGALS8LGALS3ALDH1A1HPGDTSHR | |
| SCHEMBL1177587 | 0.69 | ALDH1A1 (0.44) | LGALS8LGALS3ALDH1A1HPGDTSHR | |
| SCHEMBL2823087 | 0.68 | ALDH1A1 (0.47) | LGALS8LGALS3ALDH1A1HPGDTSHR | |
| Hydrochloric Acid SCHEMBL28079046 | 0.66 | ALDH1A1 (0.46) | LGALS8LGALS3ALDH1A1HPGDTSHR | |
| SCHEMBL2977409 | 0.66 | HSD17B10 (0.38) | ALDH1A1HPGD | |
| SCHEMBL2977405 | 0.65 | CA12 (0.39) | LGALS8LGALS3ALDH1A1HPGDTSHR | |
| SCHEMBL2626882 | 0.65 | TSHR (0.40) | LGALS8LGALS3ALDH1A1HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040235916-A1 | Thiazolyl amides and their use as antiviral drugs | SCHOHE-LOOP RUDOLF (DE) | 2004-11-25 | — | — | US | disclosed |
| EP-1401436-A1 | THIAZOLYL AMIDES AND THEIR USE AS ANTIVIRAL DRUGS | Bayer HealthCare AG (DE) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003000260-A1 | THIAZOLYL AMIDES AND THEIR USE AS ANTIVIRAL DRUGS | BAYER HEALTHCARE AG (DE) | 2003-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235916-A1 | Thiazolyl amides and their use as antiviral drugs | EIF2AK2, MAVS, ZC3HAV1 | LGALS8 2221/4885LGALS3 3161/4885ALDH1A1 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.